Design of Topical Moxifloxacin Mucoadhesive Nanoemulsion for the Management of Ocular Bacterial Infections

• Main Authors: Ahmed Adel Ali Youssef (Author), Ruchi Thakkar (Author), Samir Senapati (Author), Poorva H. Joshi (Author), Narendar Dudhipala (Author), Soumyajit Majumdar (Author)
• Format: Book
• Published: MDPI AG, 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ocular bacterial infections can lead to serious visual disability without proper treatment. Moxifloxacin (MOX) has been approved by the US Food and Drug Administration as a monotherapy for ocular bacterial infections and is available commercially as an ophthalmic solution (0.5% <i>w</i>/...